SynthesisCurrent oncology (Toronto, Ont.)2020

Expression of PD-L1 for predicting response to immune checkpoint inhibitors in metastatic urothelial carcinoma: a systematic review and meta-analysis.

J Huang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.